Boston, MA, United States of America

Ze'ev Shaked

This inventor holds 1 USPTO granted patent. Top assignee: Ilex Oncology, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ze'ev Shaked. Retrieved from https://idiyas.com/inventor/ze-ev-shaked-7oo1nc7y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ze'ev Shaked: Innovator in Cancer Treatment

Introduction

Ze'ev Shaked is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on pharmaceutical formulations that enhance the delivery of therapeutic agents to patients. With a patent portfolio that includes a groundbreaking formulation, Shaked is at the forefront of cancer research and treatment.

Latest Patents

Shaked holds a patent for a pharmaceutical formulation containing DFMO (difluoromethylornithine) for the treatment of cancer. This patent describes preparations comprising a capsule, tablet, or other dosage forms that contain a core of different types of DFMO. These preparations are designed to provide direct and constant delivery of DFMO to the entire gastrointestinal (GI) tract or specifically to the colon and rectum. The DFMO-containing granules are specially formulated to achieve both rapid and slower release of the drug, allowing for tailored therapeutic effects. The patent also details methods for achieving systemic delivery as well as direct colon delivery of DFMO, enhancing the pharmacological profile while reducing toxicity.

Career Highlights

Ze'ev Shaked is associated with Ilex Oncology, Inc., where he continues to develop innovative solutions for cancer treatment. His work has been instrumental in advancing the understanding and application of DFMO in clinical settings. Shaked's dedication to improving patient outcomes through innovative formulations is evident in his research and development efforts.

Collaborations

Shaked collaborates with James William McGinity, a fellow innovator in the field. Their partnership focuses on enhancing the efficacy and safety of cancer treatments through innovative pharmaceutical formulations.

Conclusion

Ze'ev Shaked's contributions to cancer treatment through his patented formulations highlight the importance of innovation in pharmaceuticals. His work not only advances scientific knowledge but also aims to improve the quality of life for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…